USPTO serial 99575365
FIBROMAP
Reviewed by CopyMark Law Group
Status 641Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- GILBERT, REBECCA L
- Law office
- TMEG LAW OFFICE 103
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Deadline: November 1, 2026
Need help with FIBROMAP?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Office Action issues
The USPTO has refused the mark because it describes your services, rejected the Class 9 specimen as mere advertising, and requires a physical domicile address along with clarifications for the service descriptions.
Owner
Princeton, NJ, US
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable cloud-based software for detecting and analyzing fibrosis and other fibrillar protein histological phenotypes for scientific use; Downloadable cloud-based software for scientific research, namely, for collecting, processing, and visualizing histological features and phenotypes of fibrosis and other fibrillar proteins in connection with scientific or medical research; Downloadable cloud-based software for analyzing spatially resolved tissue-based datasets; Downloadable cloud-based software for analyzing spatially resolved datasets, in particular analyzing spatially resolved single-fiber datasets and spatially resolved single-cell datasets, individually or in conjunction; Downloadable cloud-based software for visualizing spatially resolved single-fiber datasets and spatially resolved single-cell datasets and their phenotypic clusters, individually or in conjunction; Downloadable cloud-based software for analyzing, measuring and quantifying phenotypes of fibrosis or other fibrillar proteins in images using advanced computational and clustering techniques | ACTIVE | May 1, 2025 |
| 042 | Cloud computing featuring software for use in the fields of artificial intelligence; Cloud computing featuring software for use in the fields of biosciences, in particular pathology, histology, histopathology, spatial biology, cytopathology, biology, botany, pharmacology, medical, veterinary; Cloud computing featuring software for use in archiving, viewing and annotating digitized images of microscope slides; Cloud computing featuring software for use in providing digital pathology services, in particular web-based digital pathology services; Cloud computing featuring software for use in analyzing, measuring and quantifying the phenotypic traits of fibrosis or other fibrillar proteins in images using advanced computational and clustering techniques; Cloud computing featuring software for use in analyzing spatially resolved datasets, in particular analyzing spatially resolved single-fiber datasets and spatially resolved single-cell datasets, individually or in conjunction; Cloud computing featuring software for use in visualizing spatially resolved single-fiber datasets and spatially resolved single-cell datasets and their phenotypic clusters, individually or in conjunction; Cloud computing featuring software for use in associating information with digitized images of microscope slides, in particular pathological data, clinical data, clinical history data, research data, reference data, analysis data, statistical data; Cloud computing featuring software for use in quantifying phenotypes of fibrosis; Cloud computing featuring software for use in discovering novel biomarkers of fibrosis | ACTIVE | May 1, 2025 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 1, 2026 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Jul 1, 2026 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| May 1, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 1, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 1, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 1, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 21, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 2, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 2, 2026 | NWAP | NEW APPLICATION ENTERED | — |